BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 1995/8/161 分で読めます

Topical Drug Products for Over-the-Counter Human Use; Products for the Prevention of Swimmer's Ear and for the Drying of Water-Clogged Ears; Partial Stay of Final Rule

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is staying part of a final rule that established that any over-the-counter (OTC) topical otic drug products for the prevention of swimmer's ear or for the drying of water-clogged ears is not generally recognized as safe and effective and is misbranded. This action, which is being taken in response to new clinical data and a petition for stay of action, applies only to topical otic drug products for the drying of water- clogged ears. This action is part of the ongoing review of OTC drug products conducted by FDA.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

関連インサイト

ビジネスインサイト →